Thursday, May 30, 2019
Home »
» Medical News Today: Synthetic CBD may be a safe treatment for seizures
Medical News Today: Synthetic CBD may be a safe treatment for seizures
A nonintoxicating, synthetic CBD that is not easy to convert to THC and comprises inexpensive, noncannabis ingredients treated seizures safely in rats.
Related Posts:
Drinking while pregnant can have long-lasting effects on children; almost half of pregnant Kentuckians report alcohol consumption Centers for Disease Control and Prevention illustration Did you know that children of mothers who drink alcohol during pregnancy can undergo changes to their facial features, accompanied by a variety of lifelong men… Read More
Appalachian Nursing Academy for high school juniors and seniors in Appalachian counties extends application deadline to April 15 The Appalachian Nursing Academy, for high school students in Appalachia who are wondering if they would like to pursue a career in health care, has extended its application deadline to April 15. The academy is a free, … Read More
UK is ‘Centering and Celebrating Cultures in Health’ during National Public Health Week, which runs through Sunday Advocates celebrated a National Public Health Week at the University of Kentucky. By Grace Colville University of Kentucky From fostering collaborations to increase lifesaving cancer screenings, to examining the imp… Read More
Fentanyl test strips will no longer be drug paraphernalia under lawBy Sarah Ladd Kentucky Lantern Fentanyl test strips will no longer be considered drug paraphernalia in Kentucky. Gov. Andy Beshear on Friday signed a bipartisan bill decriminalizing fentanyl test strips in Kentucky after it… Read More
Medicare Advantage TV ads and other marketing will have to follow new rules aimed at stopping deception of beneficiaries Cover of report asking Medicare to act Kentucky Health News Those incessant ads and phone calls about Medicare, and other marketing devices that the federal government considers deceptive, are about to get makeovers… Read More
0 comments:
Post a Comment